Unknown

Dataset Information

Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke.


ABSTRACT: Cell transplantation therapy offers great potential to improve impairments after stroke. However, the importance of donor age on therapeutic efficacy is unclear. We investigated the regenerative capacity of transplanted cells focusing on donor age (young vs. old) for ischaemic stroke. The quantities of human mesenchymal stem cell (hMSC) secreted brain-derived neurotrophic factor in vitro and of monocyte chemotactic protein-1 at day 7 in vivo were both significantly higher for young hMSC compared with old hMSC. Male Sprague-Dawley rats subjected to transient middle cerebral artery occlusion that received young hMSC (trans-arterially at 24 h after stroke) showed better behavioural recovery with prevention of brain atrophy compared with rats that received old hMSC. Histological analysis of th

SUBMITTER: Yamaguchi S 

PROVIDER: S-EPMC6434451 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature